State Street’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Buy |
|
|||||
|
2025
Q1 | $1.67M | Sell |
|
|||||
|
2024
Q4 | $3.68M | Sell |
|
|||||
|
2024
Q3 | $18.4M | Sell |
|
|||||
|
2024
Q2 | $17.5M | Sell |
|
|||||
|
2024
Q1 | $59M | Buy |
|
|||||
|
2023
Q4 | $6.96M | Sell |
|
|||||
|
2023
Q3 | $4.82M | Sell |
|
|||||
|
2023
Q2 | $49.1M | Sell |
|
|||||
|
2023
Q1 | $84.5M | Buy |
|
|||||
|
2022
Q4 | $59.9M | Buy |
|
|||||
|
2022
Q3 | $98.2M | Sell |
|
|||||
|
2022
Q2 | $131M | Buy |
|
|||||
|
2022
Q1 | $135M | Buy |
|
|||||
|
2021
Q4 | $159M | Buy |
|
|||||
|
2021
Q3 | $141M | Buy |
|
|||||
|
2021
Q2 | $178M | Buy |
|
|||||
|
2021
Q1 | $164M | Sell |
|
|||||
|
2020
Q4 | $192M | Sell |
|
|||||
|
2020
Q3 | $116M | Sell |
|
|||||
|
2020
Q2 | $106M | Buy |
|
|||||
|
2020
Q1 | $54.8M | Buy |
|
|||||
|
2019
Q4 | $46.7M | Sell |
|
|||||
|
2019
Q3 | $42.1M | Buy |
|
|||||
|
2019
Q2 | $49.3M | Sell |
|
|||||
|
2019
Q1 | $45.6M | Buy |
|
|||||
|
2018
Q4 | $26.1M | Buy |
|
|||||
|
2018
Q3 | $31.8M | Sell |
|
|||||
|
2018
Q2 | $22.6M | Buy |
|
|||||
|
2018
Q1 | $7.68M | Buy |
|
|||||
|
2017
Q4 | $3.27M | Buy |
|
|||||
|
2017
Q3 | $1.8M | Buy |
|
|||||
|
2017
Q2 | $1.44M | Buy |
|